BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11821746)

  • 1. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
    Malm H; Corbascio M; Osterholm C; Cowan S; Larsen CP; Pearson TC; Ekberg H
    Transplantation; 2002 Jan; 73(2):293-7. PubMed ID: 11821746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely.
    Corbascio M; Ekstrand H; Osterholm C; Qi Z; Simanaitis M; Larsen CP; Pearson TC; Riesbeck K; Ekberg H
    Transpl Immunol; 2002 Jun; 10(1):55-61. PubMed ID: 12182466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
    J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF; Lin H; Wei RQ; Turka LA
    J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
    Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
    Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H; Wei RQ; Goodman RE; Bolling SF
    Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time course of CTLAIg effect on cardiac allograft rejection.
    Bolling SF; Lin H; Turka LA
    J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
    Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
    J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.